Literature DB >> 12719865

[Pansclerotic porphyria cutanea tarda after chronic exposure to organic solvents].

T Karamfilov1, M Buslau, C Dürr, W Weyers.   

Abstract

A 63 year old man developed generalized scleroderma with massive sclerotic areas, particularly in the abdominal region, four years after being diagnosed with porphyria cutanea tarda (PCT). He had almost daily exposure to organic solvents (benzene, trichlorethylene) for many years. The cutaneous fibrosis progressed dramatically leading to a pansclerosis, even though the uroporphyrin levels were borderline and the liver enzyme values were normal. Organic solvents are among those substances which can cause a cutaneous fibrosis. The unusually complicated clinical development in our patient was a combination of the two initial factors, the PCT and the long term exposure to organic solvents. The pansclerotic PCT was differentiated from a systemic sclerosis, a disabling pansclerotic morphea and a generalized morphea by means of histological examinations, the absence of a Raynaud phenomenon and the non-involvement of additional organs. Auto-antibodies typical for systemic sclerosis were negative. Using a medium dosage of UVA1 phototherapy and intensive physiotherapy, the progression of the skin disease was stopped and the sclerosis improved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719865     DOI: 10.1007/s00105-002-0448-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  23 in total

1.  Skin morphology in porphyria cutanea tarda does not improve despite clinical remission.

Authors:  K Timonen; K M Niemi; P Mustajoki
Journal:  Clin Exp Dermatol       Date:  1991-09       Impact factor: 3.470

Review 2.  Porphyria cutanea tarda: pathogenesis in relation to therapy.

Authors:  G H Elder
Journal:  Curr Probl Dermatol       Date:  1991

3.  [Sclerodermiform porphyria cutanea tarda. Ultrastructural study].

Authors:  J Ocaña; I Pérez de Vargas; M L Wilhelmi; V Crespo; R Pastor; F S Fajardo; M L Delgado
Journal:  Med Cutan Ibero Lat Am       Date:  1985

4.  Scleroderma after occupational exposure to trichlorethylene and trichlorethane.

Authors:  H Flindt-Hansen; H Isager
Journal:  Acta Derm Venereol       Date:  1987       Impact factor: 4.437

5.  Porphyria and scleroderma: a clinical and laboratory review of 12 patients.

Authors:  J A Doyle; S J Friedman
Journal:  Australas J Dermatol       Date:  1983-12       Impact factor: 2.875

Review 6.  Porphyria cutanea tarda.

Authors:  C Fritsch; K Lang; S von Schmiedeberg; K Bolsen; H Merk; P Lehmann; T Ruzicka
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  1998 Nov-Dec

7.  [Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients].

Authors:  G Goerz; G Hammer; G Wirth; O P Hornstein; G J Keller; P Altmeyer; H Holzmann; W Meigel; H Mensing; O Braun-Falco
Journal:  Hautarzt       Date:  1986-06       Impact factor: 0.751

8.  Uroporphyrin I stimulation of collagen biosynthesis in human skin fibroblasts. A unique dark effect of porphyrin.

Authors:  G Varigos; J R Schiltz; D R Bickers
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

9.  Increased mast cell numbers in the sclerotic skin of porphyria cutanea tarda.

Authors:  W Torinuki; K Kudoh; H Tagami
Journal:  Dermatologica       Date:  1989

10.  Scleroderma and occupational exposure.

Authors:  M Bovenzi; F Barbone; A Betta; M Tommasini; W Versini
Journal:  Scand J Work Environ Health       Date:  1995-08       Impact factor: 5.024

View more
  3 in total

Review 1.  Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.

Authors:  Carolina Barragán-Martínez; Cesar A Speck-Hernández; Gladis Montoya-Ortiz; Rubén D Mantilla; Juan-Manuel Anaya; Adriana Rojas-Villarraga
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

Review 2.  UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.

Authors:  Frank Breuckmann; Thilo Gambichler; Peter Altmeyer; Alexander Kreuter
Journal:  BMC Dermatol       Date:  2004-09-20

Review 3.  An overview of the cutaneous porphyrias.

Authors:  Robert Dawe
Journal:  F1000Res       Date:  2017-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.